山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (1): 39-43.doi: 10.6040/j.issn.1671-7554.0.2016.200
陈意坤1,王克涛2,王华阳3,邵倩倩3,谈万业2,宋晓彬2,曲迅3,魏奉才2
CHEN Yikun1, WANG Ketao2, WANG Huayang3, SHAO Qianqian3, TAN Wanye2, SONG Xiaobin2, QU Xun3, WEI Fengcai2
摘要: 目的 探讨驱动蛋白KIF4A对巨噬细胞不同亚群中血管生成相关因子表达的影响。 方法 THP-1细胞在PMA及不同人重组细胞因子的外界刺激下分别分化为M0、M1、M2细胞,采用ELISA技术检测此3种巨噬细胞亚群中血管生成相关因子的表达水平。利用siRNA转染敲除M0、M1、M2细胞中KIF4A的表达,采用实时定量PCR检测敲除后血管生成相关因子的表达水平。 结果 巨噬细胞M0上清中可检测到LIF、VEGF、sVEGFR1及TIMP1,而sVEGFR2、Flt-3、Leptin、LeptinR、CD40L均不表达。其中LIF、VEGF、TIMP1在M0向M1、M2分化过程中,表达差异均无统计学意义(P>0.05);sVEGFR1在M0向M1分化过程中表达差异无统计学意义(P>0.05),向M2分化过程中表达显著上调(P<0.01)。转染KIF4A siRNA后,M0与M1细胞中LIF、sVEGFR1、VEGF、TIMP1的表达差异均无统计学意义(P>0.05);M2细胞中LIF、VEGF、TIMP1表达差异均无统计学意义(P>0.05),但sVEGFR1表达水平明显降低(P<0.05)。 结论 M2细胞sVEGFR1表达水平显著上调;KIF4A参与M2细胞中sVEGFR1的表达。
中图分类号:
[1] Mantovani A, Sica A. Macrophages, innate immunity and cancer:balance, tolerance, and diversity[J]. Curr Opin Immunol, 2010, 22(2):231-237. [2] Mills CD, Lenz LL, Harris RA. A breakthrough:macrophage-directed cancer immunotherapy[J]. Cancer Res, 2016, 76(3):513-516. [3] Dirkx AE, Oude Egbrink MG, Wagstaff J, et al. Monocyte/macrophage infiltration in tumors:modulators of angiogenesis[J]. J Leukoc Biol, 2006, 80(6):1183-1196. [4] Baay M, Brouwer A, Pauwels P, et al. Tumor cells and tumor-associated macrophages:secreted proteins as potential targets for therapy [J]. Clin Dev Immunol, 2011, 2011:565187. [5] Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy [J]. Nat Rev Cancer, 2008, 8(8):592-603. [6] Ferrara N. Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis [J]. Curr Opin Hematol, 2010, 17(3):219-224. [7] Verhey KJ,Hammond JW. Traffic control:regulation of kinesin motors [J]. Nat Rev Mol Cell Biol, 2009, 10(11):765-777. [8] Yamada KH, Nakajima Y, Geyer M, et al. KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2 [J]. J Cell Sci, 2014, 127(Pt 20):4518-4530. [9] Exertier P, Javerzat S, Wang B, et al. Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5 [J]. Oncotarget, 2013, 4(12):2302-2316. [10] Hanania R, Sun HS, Xu K, et al. Classically activated macrophages use stable microtubules for matrix metalloproteinase-9(MMP-9)secretion [J]. J Biol Chem, 2012, 287(11):8468-8483. [11] Cornfine S, Himmel M, Kopp P, et al. The kinesin KIF9 and reggie/flotillin proteins regulate matrix degradation by macrophage podosomes [J]. Mol Biol Cell, 2011, 22(2):202-215. [12] Wiesner C, Faix J, Himmel M, et al. KIF5B and KIF3A/KIF3B kinesins drive MT1-MMP surface exposure, CD44 shedding, and extracellular matrix degradation in primary macrophages[J]. Blood, 2010, 116(9):1559-1569. [13] Zhao P, Gao D, Wang Q, et al. Response gene to complement 32(RGC-32)expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4 [J]. Cell Mol Immunol, 2015, 12(6):692-699. [14] Tahergorabi Z, Khazaei M. Leptin and its cardiovascular effects:focus on angiogenesis[J]. Adv Biomed Res, 2015, 4:79. [15] Chakrabarti S, Rizvi M, Morin K, et al. The role of CD40L and VEGF in the modulation of angiogenesis and inflammation[J]. Vascul Pharmacol, 2010, 53(3-4):130-137. [16] Ries C. Cytokine functions of TIMP-1 [J]. Cell Mol Life Sci, 2014, 71(4):659-672. [17] 张静,刘晓惠. 可溶性血管内皮生长因子受体1 的研究进展 [J]. 中华临床医师杂志, 2015, 9(19):3625-3629. [18] Ash J, McLeod DS, Lutty GA. Transgenic expression of leukemia inhibitory factor(LIF)blocks normal vascular development but not pathological neovascularization in the eye[J]. Mol Vis, 2005, 11:298-308. [19] Melton DW, McManus LM, Gelfond JA, et al. Temporal phenotypic features distinguish polarized macrophages in vitro [J]. Autoimmunity, 2015, 48(3):161-176. [20] Mazumdar M, Sundareshan S, Misteli T. Human chromokinesin KIF4A functions in chromosome condensation and segregation [J]. J Cell Biol, 2004, 166(5):613-620. [21] Hu CK, Coughlin M, Field CM, et al. KIF4 regulates midzone length during cytokinesis[J]. Curr Biol, 2011, 21(10):815-824. [22] Chen S, Han M, Chen W, et al. KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP [J]. Oncol Rep, 2016, 35(2):971-977. [23] Ghajar CM, George SC, Putnam AJ. Matrix metalloproteinase control of capillary morphogenesis[J]. Crit Rev Eukaryot Gene Expr, 2008, 18(3):251-278. [24] Tabouret E, Boudouresque F, Farina P, et al. MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma [J]. Neuro Oncol, 2015, 17(8):1174-1176. [25] Deryugina EI, Zajac E, Juncker-Jensen A, et al. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment[J]. Neoplasia, 2014, 16(10):771-788. |
[1] | 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31. |
[2] | 杨延军,梁静,李芳,杜令席. 常山酮对小鼠子宫内膜异位症巨噬细胞极化的调控作用[J]. 山东大学学报(医学版), 2016, 54(9): 26-31. |
[3] | 宗兆运,李霞,韩振龙,王显腾,郭春,张利宁,石永玉. 肿瘤相关巨噬细胞对肝癌细胞c-Met分子表达的影响[J]. 山东大学学报(医学版), 2016, 54(3): 14-18. |
[4] | 赵璐, 孙俊波, 魏桂梅. MRP8通过NF-κB信号通路调控痛风细胞模型中IL-1β的表达[J]. 山东大学学报(医学版), 2015, 53(6): 44-47. |
[5] | 冯青, 谭晓冬. L161982对大鼠实验性自身免疫性神经炎中巨噬细胞亚型变化的影响[J]. 山东大学学报(医学版), 2015, 53(10): 21-25. |
[6] | 刘成霞, 李明, 连海峰, 史宁. miRNA-486-5p对结肠癌细胞株SW620生物学行为的影响[J]. 山东大学学报(医学版), 2015, 53(1): 16-20. |
[7] | 付海燕, 胡占升, 杜红阳, 李潮, 包翠芬. 地黄多糖对过表达Notch1(NICD)大鼠骨髓间充质干细胞诱导分化及增殖的影响[J]. 山东大学学报(医学版), 2015, 53(1): 34-40. |
[8] | 陈更越, 张静, 丁树艳, 马莉莉, 王伟, 田园. HO-1及MIF在子痫前期患者胎盘及脐组织的表达[J]. 山东大学学报(医学版), 2014, 52(S2): 1-2. |
[9] | 董兆静,尚倩雯,郭春,张利宁,王群. RNA干扰PDCD4基因表达对巨噬细胞脂质沉积的影响[J]. 山东大学学报(医学版), 2014, 52(4): 18-21. |
[10] | 王皓1,李霞2,王超3,李国盛1,郭春1,朱法良1,张利宁1,石永玉1. 肿瘤相关巨噬细胞在肝癌上皮细胞间质转型中的作用[J]. 山东大学学报(医学版), 2014, 52(4): 8-12. |
[11] | 曹统1,王义国2. 丙型肝炎病毒核心蛋白对人源性肝细胞凋亡的影响[J]. 山东大学学报(医学版), 2014, 52(3): 37-39. |
[12] | 徐慧1,王义国2,刘长虹2,刘倩2,杜娟3. HBV在HK-2细胞内的表达及对其转分化的影响[J]. 山东大学学报(医学版), 2013, 51(3): 15-20. |
[13] | 刘露1,张雯1,陈翰祥1,郑琳1,卢翌2,王红1,唐伟1,赵蔚明1. PGRN缺失型腹膜巨噬细胞对细菌脂多糖的体外炎症应答[J]. 山东大学学报(医学版), 2013, 51(3): 58-62. |
[14] | 刘海燕1,李陪2,高辉3,朱长军2,董智雄2. 染色体驱动蛋白KIF4A对胃癌细胞迁移和转移的影响[J]. 山东大学学报(医学版), 2013, 51(12): 25-28. |
[15] | 卢园园1,李栋2,庄泳1,付金秋1,时庆2,鞠秀丽1,2. Aiolos基因过表达对白血病细胞生物学特性及化疗敏感性的影响[J]. 山东大学学报(医学版), 2013, 51(12): 46-50. |
|